Issue 7/2002
Content (6 Articles)
Homocyst(e)ine and Coronary Heart Disease
Brahmajee K. Nallamothu, A. Mark Fendrick, Gilbert S. Omenn
Standardisation of Costs
Jan B. Oostenbrink, Marc A. Koopmanschap, Frans F. H. Rutten
Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting
Ron L. Akehurst, John E. Brazier, Nigel Mathers, Caroline O’Keefe, Eva Kaltenthaler, Anne Morgan, Maria Platts, Stephen J. Walters
Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values
Gérard Duru, Jean Paul Auray, Ariel Béresniak, Michel Lamure, Abby Paine, Nicolas Nicoloyannis
A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac® in the UK
Roben Das Gupta, Julian F. Guest
Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium
Niels Neymark, Thierry Gorlia, Ines Adriaenssen, Benoit Baron, Martine Piccart